What is the benefit of treating osteoporosis with antiresorptive therapy if the FRAX probability of hip fracture is between 3% and 10%, including the number needed to treat and harm?
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Antiresorptive therapies have a favorable benefit-risk profile in reducing fracture risk for individuals with a 3%-10% hip fracture probability by FRAX, although exact NNT figures are not clearly reported.
Fields of Study & Subjects
Bone health and osteoporosis research
Hip and Femur Fractures
Menopause: Health Impacts and Treatments
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 16 March 2026
- Language
- EN